Human in vitro ADMET and prediction of human pharmacokinetics and toxicity liabilities at the discovery stage

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)110-131
Number of pages22
JournalRSC Drug Discovery Series
Volume2015-January
Issue number41
StatePublished - 2015
Externally publishedYes

Fingerprint

Pharmacokinetics
In Vitro Techniques

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Human in vitro ADMET and prediction of human pharmacokinetics and toxicity liabilities at the discovery stage. / Tsaioun, Katherine.

In: RSC Drug Discovery Series, Vol. 2015-January, No. 41, 2015, p. 110-131.

Research output: Contribution to journalArticle

@article{59ca915aac7c4b5aae10d451e7eafe7e,
title = "Human in vitro ADMET and prediction of human pharmacokinetics and toxicity liabilities at the discovery stage",
author = "Katherine Tsaioun",
year = "2015",
language = "English (US)",
volume = "2015-January",
pages = "110--131",
journal = "RSC Drug Discovery Series",
issn = "2041-3203",
publisher = "Royal Society of Chemistry",
number = "41",

}

TY - JOUR

T1 - Human in vitro ADMET and prediction of human pharmacokinetics and toxicity liabilities at the discovery stage

AU - Tsaioun, Katherine

PY - 2015

Y1 - 2015

UR - http://www.scopus.com/inward/record.url?scp=84937408713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937408713&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84937408713

VL - 2015-January

SP - 110

EP - 131

JO - RSC Drug Discovery Series

JF - RSC Drug Discovery Series

SN - 2041-3203

IS - 41

ER -